Deka Bank Deutsche Girozentrale Jazz Pharmaceuticals PLC Transaction History

Deka Bank Deutsche Girozentrale

$54.1 Billion
Q4 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 115,130 shares of JAZZ stock, worth $14.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

115,130

Previous 115,130 -0.0%

Holding current value

$14.3 Million

Previous $12.6 Million 10.19%

% of portfolio

0.03%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$100.57 - $116.37 $3.15 Million - $3.64 Million	31,283 Added 37.31%	115,130 $12.6 Million
Q2 2024 Aug 08, 2024	SELL	$103.94 - $118.98 $3.27 Million - $3.74 Million	-31,461 Reduced 27.28%	83,847 $8.91 Million
Q1 2024 Apr 24, 2024	BUY	$115.19 - $132.77 $2.74 Million - $3.16 Million	23,768 Added 25.96%	115,308 $13.9 Million
Q4 2023 Jan 24, 2024	BUY	$114.26 - $136.0 $5.07 Million - $6.04 Million	44,414 Added 94.25%	91,540 $11.2 Million
Q3 2023 Nov 13, 2023	BUY	$122.0 - $145.31 $31,964 - $38,071	262 Added 0.56%	47,126 $6.16 Million
Q2 2023 Jul 25, 2023	SELL	$122.5 - $147.16 $447,002 - $536,986	-3,649 Reduced 7.22%	46,864 $5.82 Million
Q1 2023 Apr 24, 2023	SELL	$133.98 - $160.47 $414,936 - $496,975	-3,097 Reduced 5.78%	50,513 $7.25 Million
Q4 2022 Feb 01, 2023	SELL	$129.72 - $159.85 $1.09 Million - $1.34 Million	-8,366 Reduced 13.5%	53,610 $8.44 Million
Q3 2022 Nov 02, 2022	SELL	$126.59 - $161.18 $705,739 - $898,578	-5,575 Reduced 8.25%	61,976 $8.21 Million
Q2 2022 Aug 03, 2022	BUY	$141.59 - $168.66 $86,794 - $103,388	613 Added 0.92%	67,551 $10.4 Million
Q1 2022 Apr 28, 2022	SELL	$129.64 - $160.7 $1.49 Million - $1.85 Million	-11,522 Reduced 14.69%	66,938 $10.6 Million
Q4 2021 Feb 02, 2022	BUY	$119.87 - $145.67 $3 Million - $3.64 Million	25,003 Added 46.77%	78,460 $10.3 Million
Q3 2021 Oct 22, 2021	SELL	$128.64 - $184.79 $4.66 Million - $6.69 Million	-36,192 Reduced 40.37%	53,457 $6.91 Million
Q2 2021 Aug 05, 2021	SELL	$160.2 - $186.42 $59,914 - $69,721	-374 Reduced 0.42%	89,649 $15.8 Million
Q1 2021 Apr 28, 2021	BUY	$150.19 - $173.5 $3.2 Million - $3.7 Million	21,307 Added 31.01%	90,023 $14.9 Million
Q4 2020 Mar 12, 2021	BUY	$140.71 - $165.05 $1.6 Million - $1.88 Million	11,364 Added 19.81%	68,716 $11 Million
Q3 2020 Oct 29, 2020	BUY	$105.46 - $144.13 $3.36 Million - $4.59 Million	31,828 Added 124.7%	57,352 $7.94 Million
Q2 2020 Aug 04, 2020	SELL	$95.68 - $121.88 $198,344 - $252,657	-2,073 Reduced 7.51%	25,524 $2.78 Million
Q1 2020 May 14, 2020	SELL	$87.74 - $152.74 $206,890 - $360,160	-2,358 Reduced 7.87%	27,597 $2.76 Million
Q4 2019 Feb 04, 2020	SELL	$117.65 - $153.73 $2.79 Million - $3.65 Million	-23,717 Reduced 44.19%	29,955 $4.46 Million
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $4.46 Million - $5.1 Million	-35,617 Reduced 39.89%	53,672 $6.86 Million
Q2 2019 Aug 01, 2019	BUY	$125.55 - $144.48 $7.87 Million - $9.06 Million	62,682 Added 235.58%	89,289 $12.4 Million
Q1 2019 May 10, 2019	SELL	$121.81 - $142.95 $288,446 - $338,505	-2,368 Reduced 8.17%	26,607 $4.61 Million
Q4 2018 Feb 12, 2019	BUY	$115.94 - $166.74 $274,545 - $394,840	2,368 Added 8.9%	28,975 $3.55 Million
Q3 2018 Nov 09, 2018	BUY	$161.01 - $180.57 $142,332 - $159,623	884 Added 3.44%	26,607 $0
Q2 2018 Aug 14, 2018	SELL	$146.33 - $183.18 $1.48 Million - $1.85 Million	-10,112 Reduced 28.22%	25,723 $4.51 Million
Q1 2018 May 03, 2018	SELL	$135.59 - $157.16 $1.81 Million - $2.09 Million	-13,324 Reduced 27.1%	35,835 $5.36 Million
Q3 2017 Nov 06, 2017	BUY	$142.62 - $155.6 $7.01 Million - $7.65 Million	49,159	49,159 $7.3 Million

Others Institutions Holding JAZZ

# of Institutions

514

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.8B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Jazz Pharmaceuticals PLC Transaction History